Astellas Completes Acquisition of Propella Therapeutics
TOKYO – WEBWIRE – Friday, December 22, 2023Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, Astellas) launched currently...
TOKYO – WEBWIRE – Friday, December 22, 2023Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, Astellas) launched currently...